Matches in Wikidata for { <http://www.wikidata.org/entity/Q86916349> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- Q86916349 description "article scientifique publié en 2015" @default.
- Q86916349 description "artikull shkencor i botuar më 01 shkurt 2015" @default.
- Q86916349 description "artículu científicu espublizáu en febreru de 2015" @default.
- Q86916349 description "im Februar 2015 veröffentlichter wissenschaftlicher Artikel" @default.
- Q86916349 description "scientific article published on 01 February 2015" @default.
- Q86916349 description "wetenschappelijk artikel" @default.
- Q86916349 description "наукова стаття, опублікована в лютому 2015" @default.
- Q86916349 name "[Treatment-free molecular remission achieved by combination therapy with imatinib and IFNα in CML with BIM deletion polymorphism relapsed after stop imatinib]" @default.
- Q86916349 name "[Treatment-free molecular remission achieved by combination therapy with imatinib and IFNα in CML with BIM deletion polymorphism relapsed after stop imatinib]" @default.
- Q86916349 name "[Treatment-free molecular remission achieved by combination therapy with imatinib and IFNα in CML with BIM deletion polymorphism relapsed after stop imatinib]" @default.
- Q86916349 type Item @default.
- Q86916349 label "[Treatment-free molecular remission achieved by combination therapy with imatinib and IFNα in CML with BIM deletion polymorphism relapsed after stop imatinib]" @default.
- Q86916349 label "[Treatment-free molecular remission achieved by combination therapy with imatinib and IFNα in CML with BIM deletion polymorphism relapsed after stop imatinib]" @default.
- Q86916349 label "[Treatment-free molecular remission achieved by combination therapy with imatinib and IFNα in CML with BIM deletion polymorphism relapsed after stop imatinib]" @default.
- Q86916349 prefLabel "[Treatment-free molecular remission achieved by combination therapy with imatinib and IFNα in CML with BIM deletion polymorphism relapsed after stop imatinib]" @default.
- Q86916349 prefLabel "[Treatment-free molecular remission achieved by combination therapy with imatinib and IFNα in CML with BIM deletion polymorphism relapsed after stop imatinib]" @default.
- Q86916349 prefLabel "[Treatment-free molecular remission achieved by combination therapy with imatinib and IFNα in CML with BIM deletion polymorphism relapsed after stop imatinib]" @default.
- Q86916349 P1433 Q86916349-9A195531-361F-475E-8136-0C3AF130E51F @default.
- Q86916349 P1476 Q86916349-7B5F7C3B-564D-4C5D-9D28-8DE5FE846589 @default.
- Q86916349 P2093 Q86916349-23C92581-C538-4B24-9F92-1365BDE8DB9E @default.
- Q86916349 P2093 Q86916349-46469929-0603-40ED-903B-EDCDA3E5FBBD @default.
- Q86916349 P2093 Q86916349-6CA6F69F-2254-413C-8280-A52428087567 @default.
- Q86916349 P2093 Q86916349-7A776A0B-F039-46C3-B7A2-C9520DB3B313 @default.
- Q86916349 P2093 Q86916349-981ECA66-3078-46AA-ADD9-7AB958F8DCC8 @default.
- Q86916349 P2093 Q86916349-A47AFFBC-2B33-4A30-8C51-CAB9D28E646E @default.
- Q86916349 P2093 Q86916349-A48CF8D0-FAD1-4CBA-BA04-CBDA71E1E324 @default.
- Q86916349 P2093 Q86916349-A7D1491E-CC5F-4C1E-B69B-DD9290D67833 @default.
- Q86916349 P2093 Q86916349-AEA7DA69-9B35-41AA-8741-0F60F5B4FEA7 @default.
- Q86916349 P2093 Q86916349-B08FD057-C4E2-4B4E-9D0F-282669D8F984 @default.
- Q86916349 P2093 Q86916349-C7D7E5A2-08F3-432D-823A-F86D8C335B36 @default.
- Q86916349 P2093 Q86916349-D1AD595D-DC3E-4804-84FE-AFC8C06EFC84 @default.
- Q86916349 P2093 Q86916349-ECCD14C4-F868-47A7-9894-9D712248A626 @default.
- Q86916349 P2093 Q86916349-EF530BA0-CD96-43EB-A3C1-2016FD97EB0A @default.
- Q86916349 P304 Q86916349-64972C86-7C35-4D13-BD3E-F39D2F4FD718 @default.
- Q86916349 P31 Q86916349-3472CCBF-EE9D-47A3-952B-7E23FDCC5BA3 @default.
- Q86916349 P356 Q86916349-BDA48D45-49FE-470D-8FAC-124FAC331B84 @default.
- Q86916349 P433 Q86916349-E0B852CA-4939-4EAE-9E45-EAFF7F70B4C6 @default.
- Q86916349 P478 Q86916349-99AC4CBD-224B-45BB-93FF-61D37EDA2C09 @default.
- Q86916349 P50 Q86916349-6BCD3249-C143-47AE-9D28-E3301331E3FF @default.
- Q86916349 P50 Q86916349-C33E16A7-5655-4217-82E9-A041BFF3D6CD @default.
- Q86916349 P577 Q86916349-2757D420-5EA9-43D9-8FB3-DAB388B7B32C @default.
- Q86916349 P698 Q86916349-ED74D528-801B-4B94-8CD8-9E4DA643437E @default.
- Q86916349 P921 Q86916349-E7E09F4A-55AC-4A06-BB7D-C0066E234542 @default.
- Q86916349 P356 RINKETSU.56.216 @default.
- Q86916349 P698 25765803 @default.
- Q86916349 P1433 Q27711798 @default.
- Q86916349 P1476 "[Treatment-free molecular remission achieved by combination therapy with imatinib and IFNα in CML with BIM deletion polymorphism relapsed after stop imatinib]" @default.
- Q86916349 P2093 "Daigo Akahane" @default.
- Q86916349 P2093 "Hiroaki Fujimoto" @default.
- Q86916349 P2093 "Junko H Ohyashiki" @default.
- Q86916349 P2093 "Kazuma Ohyashiki" @default.
- Q86916349 P2093 "Michiyo Asano" @default.
- Q86916349 P2093 "Moritaka Gotoh" @default.
- Q86916349 P2093 "Seiichi Okabe" @default.
- Q86916349 P2093 "Seiichiro Yoshizawa" @default.
- Q86916349 P2093 "Tamiko Suguro" @default.
- Q86916349 P2093 "Tetsuzo Tauchi" @default.
- Q86916349 P2093 "Toshihiko Kitahara" @default.
- Q86916349 P2093 "Yoshikazu Ito" @default.
- Q86916349 P2093 "Yuko Tanaka" @default.
- Q86916349 P2093 "Yuu Saito" @default.
- Q86916349 P304 "216-219" @default.
- Q86916349 P31 Q13442814 @default.
- Q86916349 P356 "10.11406/RINKETSU.56.216" @default.
- Q86916349 P433 "2" @default.
- Q86916349 P478 "56" @default.
- Q86916349 P50 Q59707129 @default.
- Q86916349 P50 Q64025696 @default.
- Q86916349 P577 "2015-02-01T00:00:00Z" @default.
- Q86916349 P698 "25765803" @default.
- Q86916349 P921 Q177094 @default.